The A-SACT (Achievement in Singapore of Cholesterol Targets) Study in Patients with Coronary Heart Disease
Autor: | Don Yin, Kheng-Thye Ho, Srinivasan Rajagopalan, Evo Alemao, Kheng-Siang Ng, Khong-Whee Chin |
---|---|
Rok vydání: | 2006 |
Předmět: |
Male
medicine.medical_specialty Statin medicine.drug_class Hypercholesterolemia Coronary Disease Disease Cohort Studies Pharmacotherapy Asian People Internal medicine medicine Humans Pharmacology (medical) Myocardial infarction Risk factor Retrospective Studies Cause of death Singapore Framingham Risk Score business.industry Anticholesteremic Agents Mortality rate Cholesterol LDL General Medicine Middle Aged medicine.disease Logistic Models Cardiology Female lipids (amino acids peptides and proteins) Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business |
Zdroj: | American Journal of Cardiovascular Drugs. 6:383-391 |
ISSN: | 1175-3277 |
DOI: | 10.2165/00129784-200606060-00005 |
Popis: | Cardiovascular disease remains a leading cause of death worldwide, with hypercholesterolemia being a major risk factor. Evidence-based consensus guidelines have recommended consideration of increasingly stringent cholesterol-lowering goals, yet most patients do not meet these targets. Coronary heart disease (CHD) event and mortality rates and mean serum cholesterol levels have declined in Singapore in recent years; however, certain groups remain at elevated risk.To determine (i) proportions of patients with CHD in Singapore who achieved goals for serum low-density lipoprotein-cholesterol (LDL-C); and (ii) factors influencing goal attainment.A historical cohort study was conducted using records from the Singapore Cardiac Databank, a national registry of CHD patients. Serum LDL-C goal attainment was assessed in 5174 survivors of acute myocardial infarction or coronary revascularization (i.e. coronary artery bypass graft surgery or percutaneous coronary interventions), of whom 3811 (73.7%) were at very high risk.At baseline, the mean patient age was 60.3 years, mean serum value of total cholesterol was 228 mg/dL, and mean LDL-C was 163 mg/dL. Of all CHD patients, approximately 70% did not achieve a serum LDL-C target of100 mg/dL. Most patients receiving HMG-CoA reductase inhibitor (statin) regimens were treated initially with low- to medium-equipotency regimens and were never titrated to stronger regimens. The vast majority (approximately 94%) of patients at very high risk did not achieve the stringent serum LDL-C target of70 mg/dL. Patients receiving higher potency statins were significantly more likely to achieve LDL-C goals, whereas those with higher baseline LDL-C levels or Malaysian ethnicity were less likely to achieve LDL-C goals.Most CHD patients in the large group of Singapore residents with CHD in the present study did not achieve recommended LDL-C targets. A more effective disease-management approach, including patient education concerning lifestyle modification (e.g. diet, physical activity), efforts to enhance medication adherence, and more effective, well tolerated therapies such as high-equipotency or high-dose statins and statin combination regimens, may be needed to improve achievement of consensus cholesterol targets. This is the first study of cholesterol goal attainment in a large group of Southeast Asians and serves as a baseline for future evaluations in Asian populations. |
Databáze: | OpenAIRE |
Externí odkaz: |